- 全部删除
您的购物车当前为空
GSK 114 是口服有活性的、高选择性的TNNI3K 抑制剂 (IC50= 25 nM)。其中TNNI3K (又称 CARK) 是酪氨酸样激酶家族的成员,选择性在心脏组织中表达。它对 TNNI3K 的选择性是 B-Raf 激酶的 40 倍 (IC50= 1 µM)。


为众多的药物研发团队赋能,
让新药发现更简单!
GSK 114 是口服有活性的、高选择性的TNNI3K 抑制剂 (IC50= 25 nM)。其中TNNI3K (又称 CARK) 是酪氨酸样激酶家族的成员,选择性在心脏组织中表达。它对 TNNI3K 的选择性是 B-Raf 激酶的 40 倍 (IC50= 1 µM)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 269 | In stock | |
| 5 mg | ¥ 629 | In stock | |
| 10 mg | ¥ 987 | In stock | |
| 25 mg | ¥ 1,980 | In stock | |
| 50 mg | ¥ 3,290 | In stock | |
| 100 mg | ¥ 4,730 | In stock | |
| 200 mg | ¥ 6,590 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 756 | In stock |
| 产品描述 | GSK-114 is a selective inhibitor of TNNI3 interacting kinase (TNNI3K) with an IC50 of 25 nM, 40-fold significant bias for TNNI3K compared to B-Raf with an IC50 of 1000 nM, so GSK-114 has excellent Broad-spectrum kinase selectivity and sufficient oral exposure enable use in cellular and in vivo studies. |
| 靶点活性 | TNNI3K:25 nM |
| 分子量 | 417.48 |
| 分子式 | C19H23N5O4S |
| CAS No. | 1301761-96-5 |
| Smiles | CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1 |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 5.5 mg/mL (13.17 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
评论内容